| Unichem Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506690 |
NSE Symbol : UNICHEMLAB |
P/E(TTM) : - |
|
ISIN Demat : INE351A01035 |
Div & Yield% : - |
EPS(TTM) : 0.37 |
|
Book Value(₹) : 325.91 |
Market Cap(₹Cr) : 4,511.25 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 389.75 | 399.24 | 362.43 | 333.83 | 346.67 | 310.06 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 389.75 | 399.24 | 362.43 | 333.83 | 346.67 | 310.06 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 8.77 | 7.04 | 77.96 | 7.58 | 5.83 | 3.79 |
| Total Income | 398.52 | 406.28 | 440.38 | 341.41 | 352.49 | 313.85 |
| Total Expenditure | 349.55 | 494.27 | 343.11 | 341.14 | 338.36 | 426.44 |
| PBIDT | 48.97 | -87.99 | 97.28 | 0.27 | 14.14 | -112.58 |
| Interest | 1.38 | 1.76 | 2.36 | 3.82 | 2.48 | 2.93 |
| PBDT | 47.59 | -89.75 | 94.92 | -3.55 | 11.66 | -115.52 |
| Depreciation | 26.11 | 25.22 | 25.62 | 27.26 | 27.36 | 28.32 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 21.48 | -114.97 | 69.30 | -30.81 | -15.70 | -143.83 |
| Extra-ordinary Items | 0.00 | -125.62 | 68.01 | 0.00 | 0.00 | -107.64 |
| Adjusted Profit After Extra-ordinary item | 21.48 | 10.65 | 1.29 | -30.81 | -15.70 | -36.19 |
| EPS (Unit Curr.) | 3.05 | -16.33 | 9.85 | -4.38 | -2.23 | -20.43 |
| EPS (Adj) (Unit Curr.) | 3.05 | -16.33 | 9.85 | -4.38 | -2.23 | -20.43 |
| Calculated EPS (Unit Curr.) | 3.05 | -16.33 | 9.84 | -4.38 | -2.23 | -20.43 |
| Calculated EPS (Adj) (Unit Curr.) | 3.05 | -16.33 | 9.84 | -4.38 | -2.23 | -20.43 |
| Calculated EPS (Ann.) (Unit Curr.) | 12.21 | -65.32 | 39.37 | -17.50 | -8.92 | -81.72 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 12.21 | -65.32 | 39.37 | -17.50 | -8.92 | -81.72 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 14.08 | 14.08 | 14.08 | 14.08 | 14.08 | 14.08 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 12.56 | -22.04 | 26.84 | 0.08 | 4.08 | -36.31 |
| PBDTM(%) | 12.21 | -22.48 | 26.19 | -1.06 | 3.36 | -37.26 |
| PATM(%) | 5.51 | -28.80 | 19.12 | -9.23 | -4.53 | -46.39 |